Robert Donald Harvey (R Donald Harvey)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 32

Top Topics

Multiple Myeloma

African American

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Robert Donald Harvey, Therica M Miller, Patricia A Hurley, Ramya Thota, Lora J Black, Suanna S Bruinooge, Leigh M Boehmer, Mark E Fleury, Jasmine Kamboj, Mujahid A Rizvi, Banu E Symington, William D Tap, David M Waterhouse, Laura A Levit, Janette K Merrill, Sheila A Prindiville, Teri Pollastro, Jamie R Brewer, Leslie P Byatt, Leila Hamroun, Edward S Kim, Nicole Holland, Grzegorz S Nowakowski
A call to action to advance patient-focused and decentralized clinical trials. Cancer 130 (8) (2024)
Robert Donald Harvey, Therica M Miller, Patricia A Hurley, Ramya Thota, Lora J Black, Suanna S Bruinooge, Leigh M Boehmer, Mark E Fleury, Jasmine Kamboj, Mujahid A Rizvi, Banu E Symington, William D Tap, David M Waterhouse, Laura A Levit, Janette K Merrill, Sheila A Prindiville, Teri Pollastro, Jamie R Brewer, Leslie P Byatt, Leila Hamroun, Edward S Kim, Nicole Holland, Grzegorz S Nowakowski
A call to action to advance patient-focused and decentralized clinical trials. Cancer (2024)
Ramya Thota, Patricia A Hurley, Therica M Miller, Suanna Steeby Bruinooge, Craig Lipset, Robert Donald Harvey, Lora J Black, Amanda Dinsdale, Janette K Merrill, Teri Pollastro, Sheila A Prindiville, Mujahid A Rizvi, Shimere Sherwood, Grzegorz S Nowakowski
Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Robert Donald Harvey, Therica M Miller, Patricia A Hurley, Ramya Thota, Lora J Black, Suanna S Bruinooge, Leigh M Boehmer, Mark E Fleury, Jasmine Kamboj, Mujahid A Rizvi, Banu E Symington, William D Tap, David M Waterhouse, Laura A Levit, Janette K Merrill, Sheila A Prindiville, Teri Pollastro, Jamie R Brewer, Leslie P Byatt, Leila Hamroun, Edward S Kim, Nicole Holland, Grzegorz S Nowakowski
A call to action to advance patient-focused and decentralized clinical trials. Cancer 130 (8) (2024)
Robert Donald Harvey, Therica M Miller, Patricia A Hurley, Ramya Thota, Lora J Black, Suanna S Bruinooge, Leigh M Boehmer, Mark E Fleury, Jasmine Kamboj, Mujahid A Rizvi, Banu E Symington, William D Tap, David M Waterhouse, Laura A Levit, Janette K Merrill, Sheila A Prindiville, Teri Pollastro, Jamie R Brewer, Leslie P Byatt, Leila Hamroun, Edward S Kim, Nicole Holland, Grzegorz S Nowakowski
A call to action to advance patient-focused and decentralized clinical trials. Cancer 130 (8) (2024)
Benjamin N Schmeusser, Arnold R Palacios, Eric R Midenberg, Reza Nabavizadeh, Dattatraya H Patil, Robert Donald Harvey, Janetta Bryksin, Michael J Connor, Kenneth Ogan, Mehmet A Bilen, Viraj A Master
Race-free renal function estimation equations and potential impact on Black patients: Implications for cancer clinical trial enrollment. Cancer 129 (6) (2023)
Benjamin N Schmeusser, Arnold R Palacios, Eric R Midenberg, Reza Nabavizadeh, Dattatraya H Patil, Robert Donald Harvey, Janetta Bryksin, Michael J Connor, Kenneth Ogan, Mehmet A Bilen, Viraj A Master
Race-free renal function estimation equations and potential impact on Black patients: Implications for cancer clinical trial enrollment. Cancer 129 (6) (2023)
Chloe S Lalonde, Jeffrey M Switchenko, Madhusmita Behera, Mehmet A Bilen, Taofeek Kunle Owonikoko, Jonathan L Kaufman, Ajay K Nooka, Colleen M Lewis, Elise Hitron, Hannah Collins, Emma C Judson, Olatunji B Alese, Robert Donald Harvey, Jennifer Wilkinson Carlisle
Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast. The oncologist (2023)
Laura F Sun, Kathryn T Maples, Kevin H Hall, Yuan Liu, Yichun Cao, Nisha S Joseph, Craig C Hofmeister, Jonathan L Kaufman, Madhav V Dhodapkar, Ajay K Nooka, Sagar Lonial, Robert Donald Harvey
Impact of Black Race on Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma Receiving Bortezomib Induction. JCO oncology practice (2023)
Benjamin N Schmeusser, Arnold R Palacios, Eric R Midenberg, Reza Nabavizadeh, Dattatraya H Patil, Robert Donald Harvey, Janetta Bryksin, Michael J Connor, Kenneth Ogan, Mehmet A Bilen, Viraj A Master
Race-free renal function estimation equations and potential impact on Black patients: Implications for cancer clinical trial enrollment. Cancer (2023)
Ash B Alpert, Lexis Rivers, Charlie Manzano, Roman Ruddick, Spencer Adams, Juno Obedin-Maliver, Robert Donald Harvey, Jennifer J Griggs, Don Operario
Debunking Sex and Disentangling Gender From Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Benedito Arruda Carneiro, Ludimila Cavalcante, Devalingam Mahalingam, Anwaar Saeed, Howard Safran, Wen Wee Ma, Andrew L Coveler, Steven Francis Powell, Bruno R Bastos, Elizabeth J Davis, Vaibhav Sahai, William Mikrut, James Longstreth, Sheri Smith, Taylor M Weiskittel, Hu Li, Brittany A Borden, Robert Donald Harvey, Solmaz Sahebjam, Andres Cervantes, Austin Koukol, Andrew P Mazar, Neeltje Steeghs, Razelle Kurzrock, Francis J Giles, Pamela N Munster
Phase 1 study of Elraglusib (9-ING-41), a glycogen synthase kinase-3b inhibitor, as monotherapy or combined with chemotherapy in patients with advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Benjamin N Schmeusser, Arnold R Palacios, Eric R Midenberg, Reza Nabavizadeh, Dattatraya H Patil, Robert Donald Harvey, Janetta Bryksin, Michael J Connor, Kenneth Ogan, Mehmet A Bilen, Viraj A Master
Race-free renal function estimation equations and potential impact on Black patients: Implications for cancer clinical trial enrollment. Cancer 129 (6) (2023)
Rachel B Jimenez, Caroline Schenkel, Laura A Levit, Bonnie Hu, Xiudong Jennifer Lei, Robert Donald Harvey, Vicki A Morrison, Teri Pollastro, David Michael Waterhouse, Colin Weekes, Grant R Williams, Suanna Steeby Bruinooge, Elizabeth Garrett-Mayer, Jeffrey M Peppercorn
Oncologists' Perspectives on Individualizing Dose Selection for Patients With Metastatic Cancer. JCO oncology practice 18 (11) (2022)
Elizabeth Lerner Papautsky, Martha Carlson, Sheila Marie Johnson, Hannah Montague, Leeann Valero, Deanna J Attai, Robert Donald Harvey, Gary H Lyman, Maryam Lustberg
Webinar as an Informational Resource on Trastuzumab Biosimilars: Planning, Promotion, Execution, and Evaluation. Cancer investigation 40 (7) (2022)
Laura A Levit, Shaily Arora, Paul G Kluetz, Allison Magnuson, Atiqur Rahman, Robert Donald Harvey
Call to Action for Improving Oral Anticancer Agent Adherence. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (10) (2022)
Edward S Kim, Thomas S Uldrick, Caroline Schenkel, Suanna Steeby Bruinooge, Robert Donald Harvey, Allison Magnuson, Alexander Spira, James L Wade, Mark D Stewart, Diana Merino Vega, Julia A Beaver, Andrea M Denicoff, Gwynn Ison, S Percy Ivy, Suzanne George, Raymond P Perez, Patricia A Spears, William D Tap, Richard L Schilsky
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Robert Donald Harvey, Kathryn F Mileham, Vishal Bhatnagar, Jamie R Brewer, Atiqur Rahman, Cassadie Moravek, Andrew S Kennedy, Elizabeth A Ness, E Claire Dees, S Percy Ivy, Scot W Ebbinghaus, Caroline Schenkel, Thomas S Uldrick
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work Group. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Jennifer J Griggs, Kari Bohlke, Edward P Balaban, James J Dignam, Evan Thomas Hall, Robert Donald Harvey, Diane P Hecht, Kelsey A Klute, Vicki A Morrison, T May Pini, Gary L Rosner, Carolyn D Runowicz, Michelle Shayne, Alex Sparreboom, Sophia Turner, Corrine Zarwan, Gary H Lyman
Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (18) (2021)
Robert Donald Harvey, Suanna Steeby Bruinooge, Li Chen, Elizabeth Garrett-Mayer, Whitney Rhodes, Edward Stepanski, Thomas S Uldrick, Gwynn Ison, Sean Khozin, Wendy S Rubinstein, Caroline Schenkel, Robert S Miller, George A Komatsoulis, Richard L Schilsky, Edward S Kim
Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non-Small Cell Lung Cancer: Real-World Analysis of Select ASCO-Friends Recommendations. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Roisin M Connolly, Eric Laille, Ulka Vaishampayan, Vincent Chung, Karen Kelly, Afshin Dowlati, Olatunji B Alese, Robert Donald Harvey, Paul Haluska, Lillian L Siu, Shivaani Kummar, Richard Piekarz, S Percy Ivy, Nicole M Anders, Melinda Downs, Ashley O'Connor, Angela Scardina, Jacqueline Saunders, Gary L Rosner, Michelle A Rudek, null null
Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (20) (2020)
Paul G Kluetz, Patricia Keegan, George D Demetri, Katherine Thornton, Joohee Sul, Janice Kim, Harvey Katzen, Laurie Beth Burke, Robert Donald Harvey, Elleni Alebachew, Sundeep Agrawal, Abhilasha Nair, Martha Donoghue, William F Pierce, Stacy S Shord, Jennifer J Gao, Richard Pazdur
FDA Oncology Center of Excellence Project Renewal: Engaging the Oncology Community to Update Product Labeling for Older Oncology Drugs. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (4) (2020)
Dylan J Martini, Yuan Liu, Viraj A Master, Robert Donald Harvey, Mehmet Asim Bilen
Reply to Body fat indices and survival in immunotherapy-treated patients with cancer. Cancer 126 (13) (2020)
Robert Donald Harvey, Val R Adams, Tyler Beardslee, Patrick Medina
Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (6) (2020)
Taofeek K Owonikoko, Robert Donald Harvey, Bradley Carthon, Zhengjia Chen, Colleen Lewis, Hanna Collins, Chao Zhang, David H Lawson, Olatunji B Alese, Mehmet Asim Bilen, Gabriel L Sica, Conor E Steuer, Walid L Shaib, Christina Wu, Wayne B Harris, Mehmet Akce, Ragini R Kudchagkar, Bassel F El-Rayes, Sagar Lonial, Suresh S Ramalingam, Fadlo Raja Khuri
A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (11) (2020)
Kevin H Hall, Yuan Liu, Chen Jiang, Robert Donald Harvey
New and Worsening Long-term Immune-Related Adverse Events with PD-1/PD-L1 Pathway Agents in Patients with Cancer. Pharmacotherapy 40 (2) (2020)
Jack W Shteamer, Robert Donald Harvey, Boris Spektor, Kimberly A Curseen, Katherine Egan, Zhengjia Chen, Theresa W Gillespie, Roman M Sniecinski, Vinita Singh
Safety of Intranasal Ketamine for Reducing Uncontrolled Cancer-Related Pain: Protocol of a Phase I/II Clinical Trial. JMIR research protocols 8 (4) (2019)
Dylan J Martini, Meredith R Kline, Yuan Liu, Julie M Shabto, Milton A Williams, Amir Ishaq Khan, Colleen Lewis, Hannah Collins, Mehmet Akce, Haydn T Kissick, Bradley C Carthon, Walid L Shaib, Olatunji B Alese, Rathi N Pillai, Conor E Steuer, Christina S Wu, David H Lawson, Ragini R Kudchadkar, Bassel F El-Rayes, Suresh R Ramalingam, Taofeek K Owonikoko, Robert Donald Harvey, Viraj A Master, Mehmet Asim Bilen
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials. Cancer 126 (3) (2019)
Mehmet Asim Bilen, Haydn T Kissick, Robert Donald Harvey
Reply to Tumor-associated macrophages: "Good cop-bad cop". Cancer 125 (11) (2019)
Robert Donald Harvey, Chao Zhang, Sagar Lonial, Jonathan L Kaufman, Zhengjia Chen
Reply to African American patients may or may not have poorer response rates after monoclonal antibody treatment: Overreliance on P values in underpowered studies. Cancer 125 (13) (2019)
Vinita Singh, Theresa W Gillespie, Robert Donald Harvey
Intranasal Ketamine and Its Potential Role in Cancer-Related Pain. Pharmacotherapy 38 (3) (2018)
Gary H Lyman, Robin Zon, Robert Donald Harvey, Richard L Schilsky
Rationale, Opportunities, and Reality of Biosimilar Medications. The New England journal of medicine 378 (21) (2018)